H.C. Wainwright Reiterates Neutral Rating on AnaptysBio (ANAB)

February 4, 2025 6:40 AM UTC Send to a Friend
H.C. Wainwright analyst Emily Bodnar reiterated a Neutral rating and $19.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented: "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login